DTNBP1 (dysbindin) gene variants modulate prefrontal brain function in healthy individuals

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• DTNBP1 (dysbindin) is implicated in schizophrenia, potentially affecting prefrontal cortex function and cognitive processes via neurotransmitter interactions, particularly glutamate.
• Previous research suggests DTNBP1's role, but its impact on systemic neurophysiological prefrontal brain function remains uncharacterized.

Purpose of the Study:

• To investigate the influence of eight DTNBP1 gene variants on the NoGo-anteriorization (NGA) event-related potential (ERP) as a marker of prefrontal brain function.
• To explore the relationship between specific DTNBP1 polymorphisms and neurophysiological measures in healthy individuals.

Main Methods:

• Studied 48 healthy individuals, examining eight DTNBP1 gene variants.
• Utilized the NoGo-anteriorization (NGA) measure, an event-related potential (ERP) derived from the continuous performance test (CPT), as a neurophysiological marker.
• Conducted post hoc analyses to examine effects on Go centroid and frontal amplitudes.

Main Results:

• Two DTNBP1 polymorphisms (P1765 and P1320), previously associated with schizophrenia, showed a significant association with alterations in the NGA.
• Post hoc analyses indicated that genetic variations at these loci influenced the Go centroid and frontal amplitudes, suggesting a modification of prefrontal cortex motor execution processes.

Conclusions:

• This study provides the first evidence of DTNBP1 gene variation influencing prefrontal brain function at a systemic neurophysiological level in healthy humans.
• The findings suggest a potential mechanism involving the modification of motor processes by the prefrontal cortex due to DTNBP1 genetic variations.
• Further research is needed to determine the relevance of these findings for schizophrenia patients.